Premium
Creating Structural Defects of Drug‐Free Copper‐Containing Layered Double Hydroxide Nanoparticles to Synergize Photothermal/Photodynamic/Chemodynamic Cancer Therapy
Author(s) -
Sun Luyao,
Wang Jingjing,
Liu Jianping,
Li Li,
Xu Zhi Ping
Publication year - 2021
Publication title -
small structures
Language(s) - English
Resource type - Journals
ISSN - 2688-4062
DOI - 10.1002/sstr.202000112
Subject(s) - photothermal therapy , indocyanine green , photodynamic therapy , chemistry , singlet oxygen , hydroxide , drug delivery , reactive oxygen species , cancer cell , in vivo , nanoparticle , cancer research , cancer , biophysics , nanotechnology , materials science , oxygen , pathology , medicine , biochemistry , organic chemistry , microbiology and biotechnology , biology
Combination therapy has been extensively studied to achieve a more efficient inhibition of tumor progression. Herein, a nanoplatform based on layered double hydroxide (LDH) nanoparticles (NPs) is specifically constructed for the effective combination breast cancer therapy without the traditional anticancer drug. Cu‐containing LDH NPs loaded with indocyanine green (ICG) are devised with more Cu coordination defects (d‐Cu‐LDH/ICG) to induce photothermal/photodynamic/chemodynamic therapy (PTT/PDT/CDT) using only one laser source. The structurally created defects on the LDH surface and dual‐function ICG molecules in the LDH interlayer significantly enhance photothermal transduction and singlet‐oxygen ( 1 O 2 ) generation at 808 nm laser irradiation. Moreover, d‐Cu‐LDH/ICG NPs generate hydroxyl radicals (·OH) in the presence of H 2 O 2 as Fenton catalysts, which are further enhanced by Cu(II) reduction with glutathione and temperature elevation. Consequently, d‐Cu‐LDH/ICG NPs significantly suppress 4T1 cell proliferation and show effective inhibition of the tumor growth in vivo through only one combined PTT/PDT/CDT under very mild laser irradiation, i.e., at 0.23 W cm −2 for 5 min with very low doses of Cu and ICG (2.5 and 0.5 mg kg −1 ). Altogether, the defect‐created d‐Cu‐LDH/ICG nanoplatform offers a new and safe treatment option for combination cancer therapy without using any anticancer drugs.